Chaired by Dean Brown, SVP and Head of Research at Jnana Therapeutics, the symposium will feature scientific presentations from leaders at Merck, Pfizer, Kymera Therapeutics, Cytokinetics, Nurix, and Vividion Therapeutics.
The program includes a keynote presentation by Jan Smith, Chief Scientific Officer at Revolution Medicines, highlighting daraxonrasib, along with discussions on emerging modalities in drug discovery and industry trends.
Agenda:
- 8:00-8:30 AM: Registration
- 8:30 AM–12:00 PM: Welcome and Molecules of the Year presentations
- 12:00–1:00 PM: Lunch
- 1:00–2:00 PM: Keynote Presentation
- 2:00–3:20 PM: Emerging Modalities in Drug Discovery
- 3:20–4:00 PM: Industry Panel Discussion and Closing Remarks
- 4:00–6:00 PM: Networking Mixer
Breakfast, lunch, and a networking happy hour are included.
Attendance is by invitation only. Interested participants are encouraged to apply to attend. General admission is listed at $1,500, with a limited number of discounted tickets available.
Any profits from the event will be donated to the American Cancer Society.
Learn more and apply to attend: https://marketing.drughunter.com/drug-hunter-molecules-of-the-year-symposium